Search Results

Filter
  • 1-10 of  20 results for ""Kelly, Deanna L.""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Urine testing for antipsychotics: a pilot trial for a method to determine detection levels.

  • Authors : Miller J; University of Maryland, School of Pharmacy, Baltimore, Maryland, USA.; Wilkes-Barre Veterans Affairs Medical Center (VAMC), Wilkes-Barre, Pennsylvania, USA.

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*urine ; Benzodiazepines/Benzodiazepines/Benzodiazepines/*urine ; Biological Assay/Biological Assay/Biological Assay/*methods

  • Source: Human psychopharmacology [Hum Psychopharmacol] 2015 Sep; Vol. 30 (5), pp. 350-5. Date of Electronic Publication: 2015 May 25.Publisher: Wiley & Sons Country of Publication: England NLM ID: 8702539 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine.

  • Authors : Weiner E; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.; Conley RR

Subjects: Schizophrenic Psychology*; Clozapine/Clozapine/Clozapine/*therapeutic use ; Risperidone/Risperidone/Risperidone/*therapeutic use

  • Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2010 Oct; Vol. 35 (11), pp. 2274-83. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone.

  • Authors : Kelly DL; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, United States. ; Wehring HJ

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Clozapine/Clozapine/Clozapine/*adverse effects ; Coronary Artery Disease/Coronary Artery Disease/Coronary Artery Disease/*chemically induced

  • Source: Schizophrenia research [Schizophr Res] 2009 Feb; Vol. 107 (2-3), pp. 134-8. Date of Electronic Publication: 2008 Nov 22.Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium: Print

Record details

×
Academic Journal

Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine.

  • Authors : Kelly DL; Maryland Psychiatric Research Center, University of Maryland, School of Medicine, Baltimore, Maryland 21228, USA. ; Conley RR

Subjects: Weight Gain*; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Benzodiazepines/Benzodiazepines/Benzodiazepines/*adverse effects

  • Source: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists [Ann Clin Psychiatry] 2008 Apr-Jun; Vol. 20 (2), pp. 71-8.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 8911021 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research.

  • Authors : McMahon RP; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland Baltimore Medical School, Baltimore, MD, USA.; Kelly DL

Subjects: Randomized Controlled Trials as Topic*; Benzodiazepines/Benzodiazepines/Benzodiazepines/*therapeutic use ; Haloperidol/Haloperidol/Haloperidol/*therapeutic use

  • Source: Schizophrenia bulletin [Schizophr Bull] 2008 Mar; Vol. 34 (2), pp. 292-301. Date of Electronic Publication: 2008 Jan 08.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0236760 Publication Model: Print-Electronic Cited Medium: Print

Record details

×
Report

Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Haloperidol/Haloperidol/Haloperidol/*adverse effects ; Psychotic Disorders/Psychotic Disorders/Psychotic Disorders/*drug therapy

  • Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2007 Aug; Vol. 27 (4), pp. 400-1.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia.

  • Authors : Kelly DL; Maryland Psychiatric Research Center, University of Maryland, Box 21247, Baltimore, 21228, USA. ; Conley RR

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Dibenzothiazepines/Dibenzothiazepines/Dibenzothiazepines/*adverse effects ; Fluphenazine/Fluphenazine/Fluphenazine/*adverse effects

  • Source: Psychoneuroendocrinology [Psychoneuroendocrinology] 2006 Apr; Vol. 31 (3), pp. 340-6. Date of Electronic Publication: 2005 Sep 28.Publisher: Pergamon Press Country of Publication: England NLM ID: 7612148 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0306-4530

Record details

×
Academic Journal

Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia.

  • Authors : Conley RR; Maryland Psychiatric Research Center, Treatment Research Unit, University of Maryland, Baltimore 21228, USA.; Kelly DL

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Dibenzothiazepines/Dibenzothiazepines/Dibenzothiazepines/*therapeutic use ; Fluphenazine/Fluphenazine/Fluphenazine/*therapeutic use

  • Source: Clinical neuropharmacology [Clin Neuropharmacol] 2005 Jul-Aug; Vol. 28 (4), pp. 163-8.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7607910 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.

  • Authors : Kelly DL; Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA. ; Conley RR

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Dibenzothiazepines/Dibenzothiazepines/Dibenzothiazepines/*therapeutic use ; Fluphenazine/Fluphenazine/Fluphenazine/*therapeutic use

  • Source: The Journal of clinical psychiatry [J Clin Psychiatry] 2005 Jan; Vol. 66 (1), pp. 80-4.Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 7801243 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.

  • Authors : Nelson MW; VA Capitol Healthcare Network Mental Illness Research Education and Clinical Care Center (MIRECC), Veterans Affairs, Maryland Health Care System, University of Maryland School of Medicine, Baltimore, MD 21228, USA. ; Reynolds RR

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Dibenzothiazepines/Dibenzothiazepines/Dibenzothiazepines/*therapeutic use

  • Source: Clinical neuropharmacology [Clin Neuropharmacol] 2003 Nov-Dec; Vol. 26 (6), pp. 297-8.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7607910 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  20 results for ""Kelly, Deanna L.""